Serveur d'exploration Tocilizumab - Curation (PubMed)

Index « Auteurs » - entrée « Masaki Shimizu »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Masaki Norimoto < Masaki Shimizu < Masaki Suemura  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 12.
Ident.Authors (with country if any)Title
000110 (2020) Hitoshi Irabu [Japon] ; Masaki Shimizu [Japon] ; Shuya Kaneko [Japon] ; Natsumi Inoue [Japon] ; Mao Mizuta [Japon] ; Yasuo Nakagishi [Japon] ; Akihiro Yachie [Japon]Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis during tocilizumab therapy.
000179 (2020) Masaki Shimizu [Japon] ; Mao Mizuta [Japon] ; Nami Okamoto [Japon] ; Takahiro Yasumi [Japon] ; Naomi Iwata [Japon] ; Hiroaki Umebayashi [Japon] ; Yuka Okura [Japon] ; Noriko Kinjo [Japon] ; Tomohiro Kubota [Japon] ; Yasuo Nakagishi [Japon] ; Kenichi Nishimura [Japon] ; Mariko Mohri [Japon] ; Masato Yashiro [Japon] ; Junko Yasumura [Japon] ; Hiroyuki Wakiguchi [Japon] ; Masaaki Mori [Japon]Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
000338 (2019) Toshiyuki Yano [Japon] ; Arata Osanami [Japon] ; Masaki Shimizu [Japon] ; Satoshi Katano [Japon] ; Nobutaka Nagano [Japon] ; Hidemichi Kouzu [Japon] ; Masayuki Koyama [Japon] ; Atsuko Muranaka [Japon] ; Ryo Harada [Japon] ; Hirosato Doi [Japon] ; Nobuyoshi Kawaharada [Japon] ; Tetsuji Miura [Japon]Utility and safety of tocilizumab in Takayasu arteritis with severe heart failure and muscle wasting.
000344 (2020) Naoto Sakumura [Japon] ; Hitoshi Irabu [Japon] ; Natsumi Inoue [Japon] ; Mao Mizuta [Japon] ; Masaki Shimizu [Japon]Clinical usefulness of longitudinal IL-6 monitoring in a patient with Takayasu aortitis receiving tocilizumab.
000426 (2019) Mao Mizuta [Japon] ; Masaki Shimizu [Japon] ; Natsumi Inoue [Japon] ; Yasuo Nakagishi [Japon] ; Akihiro Yachie [Japon]Clinical significance of serum CXCL9 levels as a biomarker for systemic juvenile idiopathic arthritis associated macrophage activation syndrome.
000758 (2018) Naoto Sakumura [Japon] ; Masaki Shimizu [Japon] ; Mao Mizuta [Japon] ; Natsumi Inoue [Japon] ; Yasuo Nakagishi [Japon] ; Akihiro Yachie [Japon]Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis.
000816 (2019) Ryuhei Yasuoka [Japon] ; Naomi Iwata [Japon] ; Naoki Abe [Japon] ; Toaki Kohagura [Japon] ; Haruna Nakaseko [Japon] ; Masaki Shimizu [Japon] ; Shinji Kawabe [Japon]Risk factors for hypersensitivity reactions to tocilizumab introduction in systemic juvenile idiopathic arthritis.
000B45 (2018) Grant S. Schulert [États-Unis] ; Francesca Minoia [Italie] ; John Bohnsack ; Randy Q. Cron ; Soah Hashad [Libye] ; Isabelle Koné-Paut [France] ; Mikhail Kostik [Russie] ; Daniel Lovell [États-Unis] ; Despoina Maritsi [Grèce] ; Peter A. Nigrovic [États-Unis] ; Priyankar Pal [Inde] ; Angelo Ravelli [Italie] ; Masaki Shimizu [Japon] ; Valda Stanevicha [Lettonie] ; Sebastiaan Vastert [Pays-Bas] ; Andreas Woerner [Suisse] ; Fabrizio De Benedetti [Italie] ; Alexei A. Grom [États-Unis]Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis.
000C42 (2017) Masaki Shimizu [Japon] ; Yasuo Nakagishi [Japon] ; Natsumi Inoue [Japon] ; Mao Mizuta [Japon] ; Akihiro Yachie [Japon]Leucine-rich α2-glycoprotein as the acute-phase reactant to detect systemic juvenile idiopathic arthritis disease activity during anti-interleukin-6 blockade therapy: A case series.
001270 (2015) Masaki Shimizu [Japon] ; Yasuhito Hamaguchi [Japon] ; Sayaka Ishikawa [Japon] ; Kazuyuki Ueno [Japon] ; Akihiro Yachie [Japon]Successful treatment with tocilizumab of a psoriasiform skin lesion induced by etanercept in a patient with juvenile idiopathic arthritis.
001822 (2012) Masaki Shimizu [Japon] ; Kazuyuki Ueno ; Akihiro YachieRelapse of systemic juvenile idiopathic arthritis after influenza vaccination in a patient receiving tocilizumab.
001898 (2012) Masaki Shimizu [Japon] ; Yasuo Nakagishi ; Kazuko Kasai ; Yuichi Yamasaki ; Mari Miyoshi ; Syuji Takei ; Akihiro YachieTocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: the diagnostic significance of interleukin-18 and interleukin-6.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/Author.i -k "Masaki Shimizu" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/Author.i  \
                -Sk "Masaki Shimizu" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    Author.i
   |clé=    Masaki Shimizu
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021